Relevant bibliographies by topics / Clinical Pharmacy and Pharmacy Practice

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Clinical Pharmacy and Pharmacy Practice'

Author: Grafiati
Published: 4 June 2021
Last updated: 21 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Clinical Pharmacy and Pharmacy Practice.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Clinical Pharmacy and Pharmacy Practice"

1

William, Kelly H. "Pulmonary Clinical Pharmacy Practice." Annals of Pharmacotherapy 40, no. 7-8 (July 2006): 1407–8. http://dx.doi.org/10.1345/aph.1g484.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Thornton, Penny. "Accountable Clinical Pharmacy Practice." Journal of Pharmacy Practice and Research 34, no. 4 (December 2004): 258–59. http://dx.doi.org/10.1002/jppr2004344258a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Taylor, George. "Clinical Pharmacy COSP -Standards of Practice for Clinical Pharmacy Services." Journal of Pharmacy Practice and Research 43, no. 2 (June 2013): 91–93. http://dx.doi.org/10.1002/j.2055-2335.2013.tb00226.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Spinewine, Anne, and Soraya Dhillon. "Clinical Pharmacy Practice: Implications for Pharmacy Education in Belgium." Pharmacy Education 2, no. 2 (January 1, 2002): 75–81. http://dx.doi.org/10.1080/1560221021000030160.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Moye, Robert A., Kim Mason, Amy Flatt, Barbara Faircloth, Janisha Livermore, Brittany Brown, Adam Furr, Cassey Starnes, John R. Yates, and Robert Hurt. "Emergency preparation and mitigation for COVID-19 response in an integrated pharmacy practice model." American Journal of Health-System Pharmacy 78, no. 8 (February 27, 2021): 705–11. http://dx.doi.org/10.1093/ajhp/zxab015.

Full text
Abstract:
Abstract Purpose The purpose of this descriptive report is to share experiences in crisis response planning and risk mitigation at a university health system department of pharmacy with an integrated clinical practice model in the early months of the coronarvirus disease 2019 (COVID-19) pandemic. Summary The department of pharmacy’s COVID-19 pandemic response included successful planning and implementation of measures to maintain pharmacy operations and minimize COVID-19 exposure of patients and staff. These measures included ensuring adequate personnel staffing using flexible staffing solutions, ongoing assessment of supply chain integrity, and continuation of integrated clinical pharmacy services 24/7 throughout the initial phase of the COVID-19 pandemic. Information technology (IT) and educational program modifications are also discussed. Conclusion This report describes successful crisis planning and risk mitigation in the setting of COVID-19, which was facilitated by the department of pharmacy’s integrated clinical practice model. This model enabled uninterrupted personnel scheduling, supply chain integrity, continued provision of 24/7 integrated clinical services, adaptive use of IT tools, and continuation of educational programs. The experiences described may be instructive to other pharmacy departments in evaluating their response to the COVID-19 pandemic and in planning for similar pandemic or other emergency scenarios.
APA, Harvard, Vancouver, ISO, and other styles
6

Hassan, Yahaya. "Challenge to Clinical Pharmacy Practice in Malaysia." Annals of Pharmacotherapy 27, no. 9 (September 1993): 1134–38. http://dx.doi.org/10.1177/106002809302700920.

Full text
Abstract:
OBJECTIVE: To report on the current status and future trends of clinical pharmacy practice in Malaysia. DATA SOURCES: Published conference reports and journal articles. DATA EXTRACTION: Data on areas related to clinical pharmacy practice in Malaysian hospitals were gleaned from various publications. DATA SYNTHESIS: Malaysia is capable of implementing clinical pharmacy services in hospitals and perhaps also in the community setting. The important factors in clinically oriented pharmacy practice include improvement of the drug-control process, development of physical and human resources, clinical pharmacy skills, and the training of practicing pharmacists. A number of Malaysian pharmacists have already developed a unit-dose drug distribution system, patient counseling, therapeutic drug monitoring, drug information, and total parenteral nutrition services. CONCLUSIONS: The pharmacy profession in Malaysia has many challenges ahead and it is hoped that every practicing pharmacist will be highly committed to future professional needs so that clinical pharmacy practice in Malaysia becomes a reality.
APA, Harvard, Vancouver, ISO, and other styles
7

Jacobi, Judith, Shaunta' Ray, Ilya Danelich, Elizabeth Dodds Ashley, Stephen Eckel, Roy Guharoy, Michael Militello, et al. "Impact of the Pharmacy Practice Model Initiative on Clinical Pharmacy Specialist Practice." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36, no. 5 (April 27, 2016): e40-e49. http://dx.doi.org/10.1002/phar.1745.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Elliott, Rohan A. "Clinical Pharmacy: an Evolving Area of Pharmacy Practice in India." Australian Journal of Hospital Pharmacy 31, no. 2 (June 2001): 147–50. http://dx.doi.org/10.1002/jppr2001312147.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Okoro, Roland N. "Ethics Education for Contemporary Clinical Pharmacy Practice in Nigeria: Shortfalls and Needs." Bangladesh Journal of Bioethics 10, no. 1 (September 5, 2020): 1–5. http://dx.doi.org/10.3329/bioethics.v10i1.48921.

Full text
Abstract:
The past decade has witnessed a shift in the ambitions of pharmacists away from the core role of dispensing medicines towards more interesting and rewarding relationships and responsibilities with other healthcare providers and patients. The patient-centred role of pharmacists has allowed ethical issues experienced in medical practice to surface in pharmacy practice, resulting in an increase in the number and variety of ethical dilemmas that pharmacists face in their routine pharmacy practice. Pharmacy education prepares pharmacy students for practice and must be in tune with the professional dynamics. Many countries that provide patient-centered pharmacy services have redesigned pharmacy ethics education while others are in various stages of revision of their curriculum in order to adequately equip future pharmacists with the rudiments required to handle ethical issues in clinical pharmacy practice. In contrast, in Nigeria, little or no pharmacy ethics is taught to pharmacy students and the challenge lies with the curriculum design and method of teaching.
APA, Harvard, Vancouver, ISO, and other styles
10

Fernandez-Llimos, Fernando, Shane Desselle, Derek Stewart, Victoria Garcia-Cardenas, Zaheer-Ud-Din Babar, Christine Bond, Ana Dago, et al. "Improving the quality of publications in and advancing the paradigms of clinical and social pharmacy practice research: The Granada statements." Pharmacy Education 23, no. 1 (February 7, 2023): 109–17. http://dx.doi.org/10.46542/pe.2023.231.109117.

Full text
Abstract:
Pharmacy and pharmaceutical sciences embrace a series of different disciplines. Pharmacy practice has been defined as “the scientific discipline that studies the different aspects of the practice of pharmacy and its impact on health care systems, medicine use, and patient care”. Thus, pharmacy practice studies embrace both clinical pharmacy and social pharmacy elements. Like any other scientific discipline, clinical and social pharmacy practice disseminates research findings using scientific journals. Clinical pharmacy and social pharmacy journal editors have a role in promoting the discipline by enhancing the quality of the articles published. As has occurred in other health care areas (i.e., medicine and nursing), a group of clinical and social pharmacy practice journal editors gathered in Granada, Spain to discuss how journals could contribute to strengthening pharmacy practice as a discipline. The result of that meeting was compiled in these Granada Statements, which comprise 18 recommendations gathered into six topics: the appropriate use of terminology, impactful abstracts, the required peer reviews, journal scattering, more effective and wiser use of journal and article performance metrics, and authors’ selection of the most appropriate pharmacy practice journal to submit their work.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Clinical Pharmacy and Pharmacy Practice"

1

Polaha, Jodi, McKenzie Highsmith, William Lusenhop, Deepu George, and Adrian Sandoval. "Clinical Evaluators Take Your Mark." Digital Commons @ East Tennessee State University, 2019. https://dc.etsu.edu/etsu-works/6881.

Full text
Abstract:
Discuss two implementation outcomes (adoption and reach) and explain why they are important for clinicians to measure and report, with application to own work Name sources of data that are accessible to clinicians in health care settings, with consideration of own setting. Describe a range of dissemination strategies used to create impact, including new ideas for dissemination of own work.
APA, Harvard, Vancouver, ISO, and other styles
2

Parsons, Laura B., and John B. Bossaer. "Differences in the Hyper-CVAD Regimen throughout Clinical Trials." Digital Commons @ East Tennessee State University, 2012. https://dc.etsu.edu/etsu-works/2355.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hess, Rick, Nicholas E. Hagemeier, Reid B. Blackwelder, Daniel Rose, Nasar Ansari, and Tandy Branham. "Teaching Communication Skills to Medical and Pharmacy Students Using a Blended Learning Course." Digital Commons @ East Tennessee State University, 2016. https://doi.org/10.5688/ajpe80464.

Full text
Abstract:
Objective. To evaluate the impact of an interprofessional blended learning course on medical and pharmacy students’ patient-centered interpersonal communication skills and to compare precourse and postcourse communication skills across first-year medical and second-year pharmacy student cohorts. Methods. Students completed ten 1-hour online modules and participated in five 3-hour group sessions over one semester. Objective structured clinical examinations (OSCEs) were administered before and after the course and were evaluated using the validated Common Ground Instrument. Nonparametric statistical tests were used to examine pre/postcourse domain scores within and across professions. Results. Performance in all communication skill domains increased significantly for all students. No additional significant pre/postcourse differences were noted across disciplines. Conclusion. Students’ patient-centered interpersonal communication skills improved across multiple domains using a blended learning educational platform. Interview abilities were embodied similarly between medical and pharmacy students postcourse, suggesting both groups respond well to this form of instruction.
APA, Harvard, Vancouver, ISO, and other styles
4

Abercrombie, Caroline, Leonard B. Cross, Sandra Alicia Williams, and Jodi Polaha. "Developing a Blueprint for Incorporating Clinical Environments Into IPE." Digital Commons @ East Tennessee State University, 2019. https://dc.etsu.edu/etsu-works/6550.

Full text
Abstract:
East Tennessee State University has successfully integrated clinical environments into its IPE curriculum, providing over 200 students from several different health professions training programs with first hand experiences in team based care. Seven partner sites host IPE groups comprised of entry-level students, providing opportunities to interact with members of the health care team, tour the active facility and interact with a patient. Our team will discuss how we navigated complex logistics and partnerships to build these experiences into our paradigm. Attendees will be challenged to think creatively about working with clinical sites outside the university setting and provided with guidance for their program. At least 40 minutes of the workshop will utilize active learning techniques. This workshop will consist of four sections, three similarly structured followed by a final reflective section. The first three sections (Building the Framework, Faculty Facilitators, and Clinical Partners) will be structured similarly. A brief introduction will prompt participants to identify potential barriers, helpful resources, and/or logistical concerns associated with each topic. This will be a small group activity where attendees share and record their discussion on a provided template. This will be followed by a brief overview of how the topic was approached for implementation of the ETSU IPE curriculum, while incorporating group responses to create a large group discussion. Our team brings the value of each representing the perspective of the various roles involved in the implementation: faculty, site leader, and director.In the fourth section, attendees will use content from the prior sections to develop a blue print for their program’s opportunities in clinical environments. Our team will answer specific questions and provide consultations with the draft of attendees’ individualized blue print. The blue print can then serve as a tool to spark the development of a strategic plan for the integration of clinical environments at their program. Learner Outcomes:At the end of this workshop, attendees are expected to be able to:1) identify potential barriers, helpful resources and logistical details for partnering with clinical sites to create IPE experiences in clinical environments;2) identify barriers and helpful resources to assist faculty in facilitating IPE groups in the clinical environment;3) create a blueprint as a guide to incorporating clinical environments into the IPE curriculum.
APA, Harvard, Vancouver, ISO, and other styles
5

Bennett, David M. "Effectiveness of clinical practice guidelines for treating asthma in the Department of Defense: A comparison of clinical and economic outcomes between the Army, Air Force, and Navy." Diss., The University of Arizona, 2002. http://hdl.handle.net/10150/280138.

Full text
Abstract:
The purpose of this research was to evaluate the strategy of the military health service (MHS) to improve asthma outcomes through the use of clinical practice guidelines (CPGs). Outcomes were evaluated at the patient level and included inpatient/outpatient visits, prescriptions dispensed, number of exacerbations, number of beddays and direct cost of therapy. In addition, provider compliance to CPG recommendations was evaluated by measuring the proportion of subjects dispensed long-acting controller medications. A nonrandomized control-group before-after design with retrospective matched-pair DoD data was used for this research. The intervention used in this research was the formal asthma CPG-use process implemented by the Army in September of 2000. Compared to baseline measures, all outcomes improved significantly (p < 0.05) in the after period for both the subjects exposed, and not exposed, to the CPG-use process. Other than the improvement noted in the number of asthma exacerbations, which was greater in the exposed group than the non-exposed group (p < 0.001), there was no other difference between groups in the amount that outcomes improved. The proportion of subjects prescribed long-term controller medications increased significantly for subjects exposed to the CPG-use process (0.30 to 0.66, p < 0.001), and for those not exposed to the CPG-use process (0.30 to 0.66, p < 0.001). Although the findings of this research suggested that a formal CPG-use process to standardize asthma therapy was associated with decreased costs, this was not supported by results regarding the clinical outcomes. To further evaluate the effect of asthma CPGs on economic and clinical outcomes, additional research is needed.
APA, Harvard, Vancouver, ISO, and other styles
6

Obiols, Albinana Laura. "Higher level practice in clinical pharmacy specialities application of the advanced level competency framework and implications for consultant pharmacists." Thesis, University College London (University of London), 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.498394.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Calhoun, McKenzie L., L. Brian Cross, and Rhonda M. Cooper-Dehoff. "Clinical Utility of Beta-Blockers for Primary and Secondary Prevention of Coronary Artery Disease." Digital Commons @ East Tennessee State University, 2013. https://doi.org/10.1586/erc.13.16.

Full text
Abstract:
Evaluation of: Bangalore S, Steg PG, Deedwania P et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA 308(13), 1340–1349 (2012). The number of myocardial infarctions (MIs) in population remains high and this event is a significant predictor of mortality. Information in the literature points to a reduction in mortality, reinfarction and sudden death in first year, especially in patients with high risk, if β-blockers (BBs) are used after MI. In a perspective study, Zuckerman et al. have determined outcome following pharmacotherapy after acute MI in older adults. It is apparent that a number of matters require consideration in evaluation of the effectiveness of BBs. It seems that not all patients benefit equally from treatment with BBs but such an intervention reduces mortality. It is also important to recognize that the beneficial effects of BBs should not be considered in isolation since the biological system is too complex to manipulate with the use of a single class of drugs.
APA, Harvard, Vancouver, ISO, and other styles
8

Hess, Rick, Nicholas E. Hagemeier, Reid Blackwelder, Daniel Rose, Nasar Ansari, and Tandy Branham. "Teaching Communication Skills to Medical and Pharmacy Students Through a Blended Learning Course." Digital Commons @ East Tennessee State University, 2016. https://dc.etsu.edu/etsu-works/1478.

Full text
Abstract:
Objective. To evaluate the impact of an interprofessional blended learning course on medical and pharmacy students’ patient-centered interpersonal communication skills and to compare precourse and postcourse communication skills across first-year medical and second-year pharmacy student cohorts. Methods. Students completed ten 1-hour online modules and participated in five 3-hour group sessions over one semester. Objective structured clinical examinations (OSCEs) were administered before and after the course and were evaluated using the validated Common Ground Instrument. Nonparametric statistical tests were used to examine pre/postcourse domain scores within and across professions. Results. Performance in all communication skill domains increased significantly for all students. No additional significant pre/postcourse differences were noted across disciplines. Conclusion. Students’ patient-centered interpersonal communication skills improved across multiple domains using a blended learning educational platform. Interview abilities were embodied similarly between medical and pharmacy students postcourse, suggesting both groups respond well to this form of instruction.
APA, Harvard, Vancouver, ISO, and other styles
9

Thomas, C. M., and John B. Bossaer. "Patient Use of Herbal Supplements in an Outpatient Hematology/Oncology Medical Clinic." Digital Commons @ East Tennessee State University, 2012. https://dc.etsu.edu/etsu-works/2356.

Full text
Abstract:
Primary Objective: According to the National Center for Health Statistics, many Americans use some type of vitamin or supplement. A recent study of cancer patients in the VA medical system found that a significant number of cancer patients do not mention the use of supplements to their healthcare providers. Many of these supplements were also found to interact with or compound side effects of chemotherapy regimens. The purpose of this study is to determine the incidence of cancer patients taking supplements and to determine the completeness of home medication lists in regard to vitamins or herbal supplements.
APA, Harvard, Vancouver, ISO, and other styles
10

Patounas, Marea. "An exploration and evaluation of the work processes of accredited pharmacists performing Home Medicines Reviews in Australia." Thesis, Queensland University of Technology, 2020. https://eprints.qut.edu.au/200066/1/Marea_Patounas_Thesis.pdf.

Full text
Abstract:
The Australian Government commenced Home Medicines Review (HMR) program funding in 2001 to promote safe and effective medicines use and to optimise prescribing in the community. However, little is known about accredited pharmacists' (APs') HMR work processes, and recent program restrictions limited HMR community access. This multiphase study explores how HMRs are conducted, the work complexity, and the service time investment performed by APs. The findings include justifying national health program reform to support in-home patient consultations of differing complexity to enable APs to better support patient medicines management and promote the Quality Use of Medicines.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Clinical Pharmacy and Pharmacy Practice"

1

Standards of practice for the pharmacy technician. Baltimore, Md: Lippincott William & Wilkins, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Omole, M. K. Controversies on clinical pharmacy programme and practice in Nigeria. Ibadan, Nigeria: Ibadan University Printery, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Clinical skills for pharmacists: A patient-focused approach. St. Louis, Mo: Mosby, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tietze, Karen J. Clinical skills for pharmacists: A patient-focused approach. 2nd ed. St. Louis, Mo: Mosby, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Greene, Russell J. Pathology and therapeutics for pharmacists: A basis for clinical pharmacy practice. London: Chapman & Hall, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

D, Harris Norman, and Goodyer Larry I, eds. Pathology and therapeutics for pharmacists: A basis for clinical pharmacy practice. London: Pharmaceutical Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Greene, Russell J. Pathology and therapeutics for pharmacists: A basis for clinical pharmacy practice. London: Chapman & Hall, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Western Regional Conference on Clinical Pharmacy Practice (1987 Coto DeCaza, Calif.). Western Regional Conference on Clinical Pharmacy Practice: January 18-20, 1987, Coto DeCaza, California. [Calif.?: The Conference, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Clinical skills for pharmacists: A patient-focused approach. 3rd ed. St. Louis, Mo: Elsevier/Mosby, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

D, Currie Jay, and American Pharmacists Association, eds. A practical guide to pharmaceutical care: A clinical skills primer. 3rd ed. Washington, DC: American Pharmacists Association, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Clinical Pharmacy and Pharmacy Practice"

1

Nagappa, A. N., and Vaishnavi Naik. "Introduction: Pharmacy Industry, Community Pharmacy, Clinical Pharmacy, and Hospital Pharmacy." In Perspectives in Pharmacy Practice, 1–12. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-9213-0_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Nagappa, A. N., and Shvetank Bhatt. "Clinical Trials, Pharmacovigilance, and Drug Safety." In Perspectives in Pharmacy Practice, 307–19. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-9213-0_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Nagappa, A. N., and Shvetank Bhatt. "Introduction to Clinical Trials and Biostatistics." In Perspectives in Pharmacy Practice, 263–77. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-9213-0_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Nagappa, A. N., and Shvetank Bhatt. "RCT, Systematic Reviews, and Evidence-Based Medicine: Randomized Clinical Trials (RCT)." In Perspectives in Pharmacy Practice, 321–32. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-9213-0_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nagappa, A. N., and Shvetank Bhatt. "Clinical Pharmacokinetics: ADME, Bioavailability and Bioequivalence, and Dosage Adjustments in CKD and Liver Disease." In Perspectives in Pharmacy Practice, 247–54. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-9213-0_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Nagappa, A. N., and Jovita Kanoujia. "Clinical Pharmacy Services: Drug and Poison Information, Ward Round Participation, Drug-Drug Interaction and Drug-Food Interaction, Prescription Analysis, PTC Activities, Formulary Management, and TDM Services." In Perspectives in Pharmacy Practice, 87–109. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-9213-0_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sullivan, Dennis M., Douglas C. Anderson, and Justin W. Cole. "Clinical Ethics in Historical Context, Part III." In Ethics in Pharmacy Practice: A Practical Guide, 63–73. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-72169-5_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Sullivan, Dennis M., Douglas C. Anderson, and Justin W. Cole. "Clinical Ethics in Historical Context, Part II." In Ethics in Pharmacy Practice: A Practical Guide, 49–61. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-72169-5_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sullivan, Dennis M., Douglas C. Anderson, and Justin W. Cole. "Clinical Ethics in Historical Context, Part I." In Ethics in Pharmacy Practice: A Practical Guide, 37–48. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-72169-5_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

"Integrating Clinical Pharmacy into Pharmacy Practice." In The Conscience of a Pharmacist, 115–28. American Society of Health-System Pharmacists, 2002. http://dx.doi.org/10.37573/9781585282852.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Clinical Pharmacy and Pharmacy Practice"

1

Welfare, Emma, and Suzanne Cutler. "0136 Developing safe clinical practice through simulation in pharmacy education." In Conference Proceedings of the Association for Simulation Practice in Healthcare (ASPiH) Annual Conference. 3rd to 5th November 2015, Brighton, UK. The Association for Simulated Practice in Healthcare, 2015. http://dx.doi.org/10.1136/bmjstel-2015-000075.134.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Perdikouri, K., C. Moraki, F. Marini, and D. Gennimata. "PS-040 Medication review in the hospital pharmacy: an everyday clinical practice or wishful thinking?" In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.546.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Barcia Martin, MI, S. Sanchez Suarez, C. Aguilar Guisado, and MM Garcia Gimeno. "5PSQ-171 Tocilizumab in patients with COVID-19: results in clinical practice." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.290.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

N’kaoua, E., E. Mestivier, E. Campana-Salort, A. Verschueren, E. Delmont, AM Grapperon, S. Attarian, and M. Roche. "5PSQ-147 Immunoglobulin shortage: practice modifications and clinical outcomes in a reference centre." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.266.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Charques Trallero, V., A. Retamero Delgado, M. Camps Ferrer, D. Ferrandez Marti, J. Serrais, RM Pares Marimon, and S. Mendiola. "4CPS-337 Persistence of biosimilar treatment for immune mediated inflammatory diseases in clinical practice." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.169.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Al-Hathal, Turfa Awrans, Lolwa Al-Ghazal, Banan Mukhalalati, Ahmed Awaisu, Alla El-Awaisi, Fatima Mraiche, Mohammad Diab, Derek Stewart, and Sara Elshami. "Examination of Job Satisfaction, Achievements, and Employment Preparedness among College of Pharmacy Alumni: A Study From Qatar." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0127.

Full text
Abstract:
Background: Job satisfaction in healthcare is of special interest as has a direct relation with the quality of care provided to patients. It is affected by several factors including the nature of the work, level of educational preparedness and achievements. Objectives: This study aims to explore College of Pharmacy - Qatar University (CPH-QU) alumni’s satisfaction with employment and the profession, level of educational preparedness and achievements in the practice. Methods: A sequential exploratory mixed-method designs was adopted. Seven Focus Group (FG) discussions were performed and a self-reported survey distributed to all alumni graduated between 2011-2020. Results: A total of 135 alumni answered the survey (response rate 63%). Majority of respondents were non-Qatari (97%) and 52% of them were recent graduates and obtained doctor of pharmacy (PharmD) as an additional degree (58%). The study findings suggest that CPH alumni are moderately satisfied with the practice and the profession, and Qatari alumni are more satisfied. However, majority of them (44.55%) are not satisfied with the available opportunities for professional development. The level of satisfaction about achievements was significantly high only in the field of research and presentation activities. A general agreement about the level of educational preparedness was dominant, especially in clinical knowledge and skills and experiential training they received. Conclusion: The overall satisfaction about workplace and the profession in CPH-QU alumni is moderate and higher among Qatari graduates. Alumni agreed that they were well prepared to meet the practice requirements and mostly satisfied in achieving research and presentation related activities.
APA, Harvard, Vancouver, ISO, and other styles
7

Barbato, L., G. Gandini, L. Benda, S. Manfre’, and P. Marini. "4CPS-232 Use of dupilumab in the treatment of atopic dermatitis in real clinical practice." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.64.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Calamanti, Chiara, Annalisa Cenci, Michele Bernardini, Emanuele Frontoni, and Primo Zingaretti. "A Clinical Decision Support System for Chronic Venous Insufficiency." In ASME 2017 International Design Engineering Technical Conferences and Computers and Information in Engineering Conference. American Society of Mechanical Engineers, 2017. http://dx.doi.org/10.1115/detc2017-68016.

Full text
Abstract:
Earlier diagnosis plays a pivotal role in clinical applications, since it can strongly reduce the incidence and impact of many diseases and, consequently, the reduction of health care costs. This last aspect depends strongly from right therapy prescriptions, especially when there are various opportunities. Within this context, Clinical Decision Support Systems (CDSS) could bring several benefits. In this paper, we propose a CDSS with the aim of improving the clinician practice based on recommendations, assessment of the patient and screening of patients with risk factors to prevent chronic venous insufficiency (CVI) complications. The proposed CDSS is implemented in the Nu.Sa. cloud system, which involves thousands of italian General Practitioners (GPs) collecting data (EHR data, personal data, patient’s medical history) from millions of patients. The proposed architecture is designed to collect data from a distributed scenario where GPs are collecting clinical history and pharmacy or second level hospitals gather data from medical devices connected to the cloud over a standard data architecture. We show that exploiting the integration of the medical device VenoScreen Plus with the patient EHR, this CDSS is capable to improve preventive care, to enhance clinical performance, to influence clinical decision making and to significantly improve the decision quality levering on data driven approach.
APA, Harvard, Vancouver, ISO, and other styles
9

Valencia Soto, CM, MV Villacañas Palomares, V. Martinez Callejo, A. García-Avello Fernández-Cueto, S. Barbadillo Villanueva, M. Ochagavia Sufrategui, P. Del Río Ortega, CA Alonso Peralta, A. Garcia De La Paz, and M. Valero Domínguez. "4CPS-268 Nivolumab versus pembrolizumab in secondline treatment of metastatic non-small cell lung cancer in clinical practice." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.100.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lomares Manzano, I., MDC Jiménez De-Juan, A. Ganfornina Andrades, and MJ Martínez Bautista. "5PSQ-169 Safety and severe neutropenia in patients treated with palbociclib and ribociclib in real world clinical practice." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.288.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Clinical Pharmacy and Pharmacy Practice"

1

Bradley, Keith, Lynsey Warwick-Giles, Katherine Checkland, Anna Coleman, Ellen Schafheutle, Sarah Willis, Ali Hindi, et al. On Primary Care: General Practice, Pharmacy, Workforce. The University of Manchester, March 2020. http://dx.doi.org/10.3927/176492314.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Totten, Annette, Dana M. Womack, Marian S. McDonagh, Cynthia Davis-O’Reilly, Jessica C. Griffin, Ian Blazina, Sara Grusing, and Nancy Elder. Improving Rural Health Through Telehealth-Guided Provider-to-Provider Communication. Agency for Healthcare Research and Quality, December 2022. http://dx.doi.org/10.23970/ahrqepccer254.

Full text
Abstract:
Objectives. To assess the use, effectiveness, and implementation of telehealth-supported provider-to-provider communication and collaboration for the provision of healthcare services to rural populations and to inform a scientific workshop convened by the National Institutes of Health Office of Disease Prevention on October 12–14, 2021. Data sources. We conducted a comprehensive literature search of Ovid MEDLINE®, CINAHL®, Embase®, and Cochrane CENTRAL. We searched for articles published from January 1, 2015, to October 12, 2021, to identify data on use of rural provider-to-provider telehealth (Key Question 1) and the same databases for articles published January 1, 2010, to October 12, 2021, for studies of effectiveness and implementation (Key Questions 2 and 3) and to identify methodological weaknesses in the research (Key Question 4). Additional sources were identified through reference lists, stakeholder suggestions, and responses to a Federal Register notice. Review methods. Our methods followed the Agency for Healthcare Research and Quality Methods Guide (available at https://effectivehealthcare.ahrq.gov/topics/cer-methods-guide/overview) and the PRISMA reporting guidelines. We used predefined criteria and dual review of abstracts and full-text articles to identify research results on (1) regional or national use, (2) effectiveness, (3) barriers and facilitators to implementation, and (4) methodological weakness in studies of provider-to-provider telehealth for rural populations. We assessed the risk of bias of the effectiveness studies using criteria specific to the different study designs and evaluated strength of evidence (SOE) for studies of similar telehealth interventions with similar outcomes. We categorized barriers and facilitators to implementation using the Consolidated Framework for Implementation Research (CFIR) and summarized methodological weaknesses of studies. Results. We included 166 studies reported in 179 publications. Studies on the degree of uptake of provider-to-provider telehealth were limited to specific clinical uses (pharmacy, psychiatry, emergency care, and stroke management) in seven studies using national or regional surveys and claims data. They reported variability across States and regions, but increasing uptake over time. Ninety-seven studies (20 trials and 77 observational studies) evaluated the effectiveness of provider-to-provider telehealth in rural settings, finding that there may be similar rates of transfers and lengths of stay with telehealth for inpatient consultations; similar mortality rates for remote intensive care unit care; similar clinical outcomes and transfer rates for neonates; improvements in medication adherence and treatment response in outpatient care for depression; improvements in some clinical monitoring measures for diabetes with endocrinology or pharmacy outpatient consultations; similar mortality or time to treatment when used to support emergency assessment and management of stroke, heart attack, or chest pain at rural hospitals; and similar rates of appropriate versus inappropriate transfers of critical care and trauma patients with specialist telehealth consultations for rural emergency departments (SOE: low). Studies of telehealth for education and mentoring of rural healthcare providers may result in intended changes in provider behavior and increases in provider knowledge, confidence, and self-efficacy (SOE: low). Patient outcomes were not frequently reported for telehealth provider education, but two studies reported improvement (SOE: low). Evidence for telehealth interventions for other clinical uses and outcomes was insufficient. We identified 67 program evaluations and qualitative studies that identified barriers and facilitators to rural provider-to-provider telehealth. Success was linked to well-functioning technology; sufficient resources, including time, staff, leadership, and equipment; and adequate payment or reimbursement. Some considerations may be unique to implementation of provider-to-provider telehealth in rural areas. These include the need for consultants to better understand the rural context; regional initiatives that pool resources among rural organizations that may not be able to support telehealth individually; and programs that can support care for infrequent as well as frequent clinical situations in rural practices. An assessment of methodological weaknesses found that studies were limited by less rigorous study designs, small sample sizes, and lack of analyses that address risks for bias. A key weakness was that studies did not assess or attempt to adjust for the risk that temporal changes may impact the results in studies that compared outcomes before and after telehealth implementation. Conclusions. While the evidence base is limited, what is available suggests that telehealth supporting provider-to-provider communications and collaboration may be beneficial. Telehealth studies report better patient outcomes in some clinical scenarios (e.g., outpatient care for depression or diabetes, education/mentoring) where telehealth interventions increase access to expertise and high-quality care. In other applications (e.g., inpatient care, emergency care), telehealth results in patient outcomes that are similar to usual care, which may be interpreted as a benefit when the purpose of telehealth is to make equivalent services available locally to rural residents. Most barriers to implementation are common to practice change efforts. Methodological weaknesses stem from weaker study designs, such as before-after studies, and small numbers of participants. The rapid increase in the use of telehealth in response to the Coronavirus disease 2019 (COVID-19) pandemic is likely to produce more data and offer opportunities for more rigorous studies.
APA, Harvard, Vancouver, ISO, and other styles
3

Apiyo, Eric, Zita Ekeocha, Stephen Robert Byrn, and Kari L. Clase. Improving Pharmacovigilliance Quality Management System in the Pharmacy and Poisions Board of Kenya. Purdue University, December 2021. http://dx.doi.org/10.5703/1288284317444.

Full text
Abstract:
The purpose of this study was to explore ways of improving the pharmacovigilance quality system employed by the Pharmacy and Poisons Board of Kenya. The Pharmacy and Poisons Board of Kenya employs a hybrid system of pharmacovigilance that utilizes an online system of reporting pharmacovigilance incidences and a physical system, where a yellow book is physically filled by the healthcare worker and sent to the Pharmacy and Poisons Board for onward processing. This system, even though it has been relatively effective compared to other systems employed in Africa, has one major flaw. It is a slow and delayed system that captures the data much later after the fact and the agency will always be behind the curve in controlling the adverse incidents and events. This means that the incidences might continue to arise or go out of control. This project attempts to develop a system that would be more proactive in the collection of pharmacovigilance data and more predictive of pharmacovigilance incidences. The pharmacovigilance system should have the capacity to detect and analyze subtle changes in reporting frequencies and in patterns of clinical symptoms and signs that are reported as suspected adverse drug reactions. The method involved carrying out a thorough literature review of the latest trends in pharmacovigilance employed by different regulatory agencies across the world, especially the more stringent regulatory authorities. A review of the system employed by the Pharmacy and Poisons Board of Kenya was also done. Pharmacovigilance data, both primary and secondary, were collected and reviewed. Media reports on adverse drug reactions and poor-quality medicines over the period were also collected and reviewed. An appropriate predictive pharmacovigilance tool was also researched and identified. It was found that the Pharmacy and Poisons Board had a robust system of collecting historical pharmacovigilance data both from the healthcare workers and the general public. However, a more responsive data collection and evaluation system is proposed that will help the agency achieve its pharmacovigilance objectives. On analysis of the data it was found that just above half of all the product complaints, about 55%, involved poor quality medicines; 15% poor performance, 13% presentation, 8% adverse drug reactions, 7% market authorization, 2% expired drugs and 1% adulteration complaints. A regulatory pharmacovigilance prioritization tool was identified, employing a risk impact analysis was proposed for regulatory action.
APA, Harvard, Vancouver, ISO, and other styles
4

Shiihi, Solomon, U. G. Okafor, Zita Ekeocha, Stephen Robert Byrn, and Kari L. Clase. Improving the Outcome of GMP Inspections by Improving Proficiency of Inspectors through Consistent GMP Trainings. Purdue University, November 2021. http://dx.doi.org/10.5703/1288284317433.

Full text
Abstract:
Approximately 90% of the pharmaceutical inspectors in a pharmacy practice regulatory agency in West Africa have not updated their training on Good Manufacturing Practice (GMP) inspection in at least eight years. However, in the last two years the inspectors relied on learning-on-the job skills. During this time, the agency introduced about 17% of its inspectors to hands-on GMP trainings. GMP is the part of quality assurance that ensures the production or manufacture of medicinal products is consistent in order to control the quality standards appropriate for their intended use as required by the specification of the product. Inspection reports on the Agency’s GMP inspection format in-between 2013 to 2019 across the six geopolitical zones in the country were reviewed retrospectively for gap analysis. Sampling was done in two phases. During the first phase sampling of reports was done by random selection, using a stratified sampling method. In the second phase, inspectors from the Regulatory Agency from different regions were contacted on phone to send in four reports each by email. For those that forwarded four reports, two, were selected. However for those who forwarded one or two, all were considered. Also, the Agency’s inspection format/checklist was compared with the World Health Organization (WHO) GMP checklist and the GMP practice observed. The purpose of this study was to evaluate the reporting skills and the ability of inspectors to interpret findings vis-à-vis their proficiency in inspection activities hence the efficiency of the system. Secondly, the study seeks to establish shortfalls or adequacies of the Agency’s checklist with the aim of reviewing and improving in-line with best global practices. It was observed that different inspectors have different styles and methods of writing reports from the same check-list/inspection format, leading to non-conformances. Interpretations of findings were found to be subjective. However, it was also observed that inspection reports from the few inspectors with the hands-on training in the last two year were more coherent. This indicates that pharmaceutical inspectors need to be trained regularly to increase their knowledge and skills in order to be kept on the same pace. It was also observed that there is a slight deviation in placing sub indicators under the GMP components in the Agency’s GMP inspection format, as compared to the WHO checklist.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Clinical Pharmacy and Pharmacy Practice' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography